Merge gets new price target: 4 things to know

Topeka Capital Markets increased Merge Healthcare’s price target from $4.50 to $5.25 in a report sent to investors Monday morning, according to WKRB 13. Here are four things to know about the new increase:

Advertisement

1. Merge Healthcare’s 52-week low is $1.97, with a 52-week high of $4.73.

2. The 50-day moving average of Merge’s stock is $4 and their 200-day moving average is $3.

3. Merge’s market cap is $434.25 million

4. Merge is expected to post $0.21 EPS for the current fiscal year, according to analysts.

 

More articles on ASC news:

FDA advisory panel to discuss ‘superbug’ infections
4 considerations for ASC administrators looking to hire
Uber investor Bill Gurley criticizes the healthcare field

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Uncategorized

Advertisement

Comments are closed.